These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
60 related articles for article (PubMed ID: 7036778)
1. Tumor-directed immunity in neuroblastoma patients and their related and unrelated contacts. Morrison LJ; Cochran AJ; Baird GM; Campbell AM; Willoughby ML Am J Pediatr Hematol Oncol; 1981; 3(4):353-61. PubMed ID: 7036778 [TBL] [Abstract][Full Text] [Related]
2. Tumor-directed immunity in human neuroblastoma. Morrison LJ; Cochran AJ; Baird GM; Campbell AM; Willoughby ML Am J Pediatr Hematol Oncol; 1982; 4(1):3-9. PubMed ID: 7046494 [TBL] [Abstract][Full Text] [Related]
3. Distribution of natural antibody against human neuroblastoma among children with or without neuroblastoma. Fukuda M; Nozaki C; Ishiguro Y; Horibe K Med Pediatr Oncol; 2001 Jan; 36(1):147-8. PubMed ID: 11464870 [TBL] [Abstract][Full Text] [Related]
4. Natural antibody against neuroblastoma among Japanese children with or without neuroblastoma. Fukuda M; Nozaki C; Ishiguro Y; Horibe K Cancer; 1999 Nov; 86(10):2166-70. PubMed ID: 10570448 [TBL] [Abstract][Full Text] [Related]
5. Sensitisation of neuroblastoma patients and related and unrelated contacts to neuroblastoma extracts. Graham-Pole J; Ogg LJ; Ross CE; Cochran AJ Lancet; 1976 Jun; 1(7974):1376-9. PubMed ID: 59016 [TBL] [Abstract][Full Text] [Related]
6. Functional characterisation of autoantibodies from patients with pediatric opsoclonus-myoclonus-syndrome. Korfei M; Fühlhuber V; Schmidt-Wöll T; Kaps M; Preissner KT; Blaes F J Neuroimmunol; 2005 Dec; 170(1-2):150-7. PubMed ID: 16203043 [TBL] [Abstract][Full Text] [Related]
7. Flow cytometric analysis of peripheral blood and bone marrow for tumor cells in patients with neuroblastoma. Komada Y; Zhang XL; Zhou YW; Inaba H; Deguchi T; Azuma E; Sakurai M Cancer; 1998 Feb; 82(3):591-9. PubMed ID: 9452279 [TBL] [Abstract][Full Text] [Related]
8. High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas. Eggert A; Ikegaki N; Kwiatkowski J; Zhao H; Brodeur GM; Himelstein BP Clin Cancer Res; 2000 May; 6(5):1900-8. PubMed ID: 10815914 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of cell mediated immunity in healthy contacts of leprosy. Kurhade AM; Akulwar SL; Pathak AA; Thakar YS; Dhanvijay AG Indian J Pathol Microbiol; 1996 Jul; 39(3):197-201. PubMed ID: 8972148 [TBL] [Abstract][Full Text] [Related]
12. Test of leukocyte migration inhibition. II. Comparative study of the techniques in capillary tubes and in agarose. Stanciu L; Urcan S; Radu D; Itu I; Popescu S Med Interne; 1984; 22(1):67-70. PubMed ID: 6710051 [TBL] [Abstract][Full Text] [Related]
13. High-dose cyclophosphamide inhibition of humoral immune response to murine monoclonal antibody 3F8 in neuroblastoma patients: broad implications for immunotherapy. Kushner BH; Cheung IY; Kramer K; Modak S; Cheung NK Pediatr Blood Cancer; 2007 Apr; 48(4):430-4. PubMed ID: 16421906 [TBL] [Abstract][Full Text] [Related]
14. Antigen-specific immunity in neuroblastoma patients: antibody and T-cell recognition of NY-ESO-1 tumor antigen. Rodolfo M; Luksch R; Stockert E; Chen YT; Collini P; Ranzani T; Lombardo C; Dalerba P; Rivoltini L; Arienti F; Fossati-Bellani F; Old LJ; Parmiani G; Castelli C Cancer Res; 2003 Oct; 63(20):6948-55. PubMed ID: 14583496 [TBL] [Abstract][Full Text] [Related]
15. A novel metastatic animal model reflecting the clinical appearance of human neuroblastoma: growth arrest of orthotopic tumors by natural, cytotoxic human immunoglobulin M antibodies. Engler S; Thiel C; Förster K; David K; Bredehorst R; Juhl H Cancer Res; 2001 Apr; 61(7):2968-73. PubMed ID: 11306475 [TBL] [Abstract][Full Text] [Related]
16. Progression of natural immunity during one-year treatment of residual disease in neuroblastoma patients with high doses of interleukin-2 after autologous bone marrow transplantation. Martí F; Pardo N; Peiró M; Bertran E; Amill B; García J; Cubells J; Rueda F Exp Hematol; 1995 Dec; 23(14):1445-52. PubMed ID: 8542930 [TBL] [Abstract][Full Text] [Related]
17. [Leukocyte migration inhibition test in healthy children]. Modzelewska I; Piórkowska E; Jankowska I Probl Med Wieku Rozwoj; 1982; 11():103-6. PubMed ID: 7178074 [TBL] [Abstract][Full Text] [Related]
18. Initial characterization of the apoptosis-inducing receptor for natural human anti-neuroblastoma IgM. David K; Heiligtag S; Ollert MW; Teppke M; Vogel CW; Bredehorst R Med Pediatr Oncol; 2001 Jan; 36(1):251-7. PubMed ID: 11464898 [TBL] [Abstract][Full Text] [Related]
19. Neuroblastoma-induced inhibition of dendritic cell IL-12 production via abrogation of CD40 expression. Walker SR; Redlinger RE; Barksdale EM J Pediatr Surg; 2005 Jan; 40(1):244-9; discussion 249-50. PubMed ID: 15868592 [TBL] [Abstract][Full Text] [Related]
20. Increased retinoic acid receptor gamma expression suppresses the malignant phenotype and alters the differentiation potential of human neuroblastoma cells. Marshall GM; Cheung B; Stacey KP; Camacho ML; Simpson AM; Kwan E; Smith S; Haber M; Norris MD Oncogene; 1995 Aug; 11(3):485-91. PubMed ID: 7630632 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]